Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
D000284:Administration, Oral; D000328:Adult; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004280:Dobutamine / Q000494:pharmacology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002316:Cardiotonic Agents; D004983:Ethanolamines; D014665:Vasodilator Agents; D004280:Dobutamine; C009118:pirbuterol